AssetMark’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
AssetMark's RARE Position: Q3 2026 in Review
AssetMark increased its Ultragenyx Pharmaceutical (RARE) stake by 59% in Q3 2026, buying an estimated $20.6K and bringing the position to 2,304 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2028.
AssetMark first reported a position in RARE in Q4 2015 and has held it in 20 quarters since. The position peaked at $322K in Q1 2022. 190 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- AssetMark held 2,304 shares of Ultragenyx Pharmaceutical worth $34.6K as of Q3 2026.
- AssetMark bought 857 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $20.6K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2028 holding.
- AssetMark first reported a position in Ultragenyx Pharmaceutical in Q4 2015 and has held it in 20 quarters since.
- AssetMark's Ultragenyx Pharmaceutical position peaked at $322K in Q1 2022.
- 190 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.